The Design and Development of Novel Drugs and Vaccines: Principles and Protocols - Softcover

9780128214718: The Design and Development of Novel Drugs and Vaccines: Principles and Protocols

Softcover

ISBN 10: 0128214716 ISBN 13: 9780128214718

Verlag: Academic Press, 2021

The Design and Development of Novel Drugs and Vaccines: Principles and Protocols presents both in silico methods and experimental protocols for vaccine and drug design and development, critically reviewing the most current research and emphasizing approaches and technologies that accelerate and lower the cost of product development. Sections review the technologies and approaches used to identify, characterize and establish a protein as a new drug and vaccine target, cover several molecular methods for in vitro studies of the desired target, and present various physiological parameters for in vivo studies. The book includes preclinical trials and research, along with information on FDA approval.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

�ber die Autorinnen und Autoren

Tarun Kumar Bhatt is an Assistant Professor in the Department of Biotechnology, at the Central University of Rajasthan, India. He received his PhD from the International Centre for Genetic Engineering and Biotechnology, New Delhi and gained post-doctoral experience at the Scripps Research Institute in San Diego, California. He has published over 25 articles and has extensive experience researching drug and vaccine development.

Surendra Nimesh, UGC Assistant Professor at Central University of Rajasthan, Rajasthan, India. Surendra received his M.S. in Biomedical Science from the Dr. B.R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi. He completed his PhD. In Nanotechnology at the Institute of Genomics and Integrative Biology (CSIR), Delhi. After completing his postdoctoral studies at the Ecole Polyetchnique of Montreal, Surendra joined the Clinical Research Institute of Montreal (IRCM), Canada as Postdoctoral Fellow. After completing his commitment at IRCM, he joined McGill University for short time. He also worked as NSERC visiting fellow at Health Canada, Canada. His research interests include nanoparticles-mediated gene, siRNA and drug delivery.

Von der hinteren Coverseite

Vaccine and drug development has proven massively important for combating infectious disease. Despite huge success, a critical need nevertheless remans for new and effective vaccines and drugs. In turn, accelerating growth in bioinformatic techniques and applications, and large amounts of experimental data, have transformed the vaccine and drug development landscape. Consequently, there is a need for a holistic overview of both the in silico and experimental methods and protocols needed to develop drug and vaccine candidates. Design and Development of Novel Vaccines presents both in silico methods and experimental protocols for vaccine and drug design and development in a single volume, critically reviewing the most current research, giving emphasis to approaches and technologies that accelerate and lower the cost of product development. Consisting in three parts, the book first reviews the technologies and approaches used to identify, characterize and establish a protein as a new drug and vaccine target, using bioinformatics; second, it covers several molecular methods for in vitro studies of the desired target; third, it presents various physiological parameters for in vivo studies. The book includes an overview of preclinical trials and clinical research, and information on FDA approval. This title presents, in a single holistic volume, essential knowledge and solutions for those working on novel vaccine and drug design.

��ber diesen Titel� kann sich auf eine andere Ausgabe dieses Titels beziehen.

Verlag: Academic Press
Erscheinungsdatum: 2021
Sprache: Englisch
ISBN 10: 0128214716
ISBN 13: 9780128214718
Einband: Taschenbuch
Anzahl der Seiten: 308
Herausgeber: Bhatt Tarun Kumar, Nimesh Surendra
Kontakt zum Hersteller: Academic Press
https://shop.elsevier.com/

230 PARK AVENUE, SUITE 800
NY
NY
10169
USA
Verantwortliche Person: Zeitfracht Medien GmbH
produktsicherheit@zeitfracht.de

Ferdinand-J�hlke-Stra�e 7
Erfurt
99095
Deutschland